Regenecure

Regenerative Polymeric Membrane for Bone Reconstruction

Health Tech & Life Sciences
Non Active, Jul 2016
Seed Jerusalem Founded 2010
Total raised
$3.5M
Last: Seed
Stage
Seed
Founded
2010
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Regenecure is dedicated to developing and marketing solutions for bone reconstruction. The companys regenerative, biocompatible, polymeric membrane implants are made of microporous ammonio methacrylate copolymer type A and a plasticizer. The microporous surface of the membrane facilitates the adherence of stem cells (MSCs) recruited to the injured site through a signaling mechanism known as chemotaxis. The membrane allows excellent proliferation and differentiation of MSCs into the bone tissue. The membrane implant is strong and flexible, and serves as an effective barrier to prevent connective tissue from infiltrating the healing space and slowing the regenerative healing process. Regenecures implant can be shaped into a tube or a patch to span large, segmental bone defects. The osteoconductive and osteoinductive qualities of the membrane ensure that Regenecures MSC scaffolding method directs bone in-growth naturally into the tubular implant. The membrane implant operates as a delivery system for cells and as a device for guided bone regeneration or tissue engineering purposes. It can also be used to deliver active agents such as osteoinductive agents, antiseptic agents, and more.

Funding history · 1 round · $3.5M total

Date unknown
Seed $3.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplantsPolymers
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

medical-technologiesregenerative-medicinetissue-regenerationorthopedicspolymersadherencestem-cellsbiomaterialscell-therapybonedoctorshospitals